We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · February 23, 2021

Ingenol Mebutate for Treating Squamous Cell Carcinoma In Situ

Journal of Drugs in Dermatology


Additional Info

Journal of Drugs in Dermatology
Ingenol Mebutate as Treatment of Squamous Cell Carcinoma In Situ: A Case Series
J Drugs Dermatol 2021 Feb 01;20(2)169-171, Y Khalfe, T Rosen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading